Cambridge, MA, United States of America

Sophia Mundle

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Sanofi Pasteur Biologics, LLC, Sanofi Pasteur Inc.. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sophia Mundle. Retrieved from https://idiyas.com/inventor/sophia-mundle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Sophia Mundle - Innovator in Herpesvirus Research

Introduction

Sophia Mundle is an accomplished inventor based in the United States. She has made significant contributions to the field of virology, particularly in the development of herpesvirus compositions and related methods. Despite having no patents to her name, her research has the potential to impact the medical community significantly.

Latest Patents

Mundle's latest patents focus on innovative approaches to herpesvirus compositions. One of her notable works is titled "Herpesvirus Compositions And Related Methods." This patent discusses liquid and dried compositions that comprise a live, attenuated, or genetically modified herpesvirus. The methods of preparing these compositions involve at least two or more pharmaceutically acceptable excipients, including histidine and a sugar or sugar alcohol. These compositions are designed to retain a sufficiently high infectious titre following storage or large-scale manufacturing steps, such as lyophilization. Another significant patent is "Purification Of Herpes Virus," which provides a method to prepare purified enveloped viral particle preparations using ion exchange chromatography and tangential flow filtration.

Career Highlights

Throughout her career, Sophia Mundle has focused on advancing the understanding and treatment of herpesvirus infections. Her innovative research has laid the groundwork for future developments in antiviral therapies.

Collaborations

Mundle has collaborated with notable colleagues, including Stephen Anderson and Simon Delagrave. Their combined expertise has contributed to the advancement of her research projects.

Conclusion

Sophia Mundle is a dedicated inventor whose work in herpesvirus research showcases her commitment to improving medical treatments. Her innovative approaches have the potential to lead to significant advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…